Leveraging Data, Performance Indicators, and Automation to Optimize the Health System Pharmacy

One of our experts shares his insights on how this ultimately supports the broader health system’s adaptability and growth.

By Andrew Wilson

Date

November 13, 2024

Read Time

2 minutes

Hospitals and health systems face a multitude of challenges in their day-to-day operations, including increased competition and intricate regulatory shifts. To bolster financial and operational performance in this complex environment, many are looking toward areas of their business that may have been underutilized in the past – like the pharmacy.

Health system pharmacies present a compelling opportunity to provide system-wide success financially, operationally, and – most importantly – in patient care, provided the pharmacy has taken steps to optimize its own operations and embrace automation. Andrew Wilson, chief pharmacy officer and VP, Professional & Advisory Services (P&AS), McKesson Health Systems, recently shared his insights on this topic with Pharmacy Times. Read the full article here.

To learn more about partnering with McKesson’s P&AS team to achieve more, contact us directly at pas@mckesson.com.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Leveraging Data, Performance Indicators, and Automation to Optimize the Health System Pharmacy

Related Stories

Related Tags